Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Drug-related lupus in a patient with rheumatoid arthritis under sulfasalazine treatment.

Literature DB >> 8102951

Drug-related lupus in a patient with rheumatoid arthritis under sulfasalazine treatment.

K Wildhagen¹, K Hartung, M Hammer, W Mau, R E Schmidt, H Deicher, H Zeidler.

Abstract

The induction of lupus-like syndromes with the appearance of single-stranded DNA antibodies is a well-known complication of drug therapy. In this report we present a patient with an erosive seropositive rheumatoid arthritis developing the clinical and serological features of systemic lupus erythematosus including the occurrence of double-stranded DNA antibodies under sulfasalazine treatment.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1993 PMID： 8102951 DOI： 10.1007/bf02231540

Source DB: PubMed Journal: Clin Rheumatol ISSN： 0770-3198 Impact factor: 2.980

13 in total

1. Sulphasalazine induced autoimmune syndrome.

Authors: T Vyse; A K So
Journal: Br J Rheumatol Date: 1992-02

2. Sulphasalazine-induced cerebral lupus erythematosus.

Authors: P Rafferty; A C Young; M R Haeney
Journal: Postgrad Med J Date: 1982-02 Impact factor: 2.401

3. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors: F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal: Arthritis Rheum Date: 1988-03

4. Sulfasalazine-induced lupus syndrome in a patient with Crohn's disease.

Authors: D L Carr-Locke
Journal: Am J Gastroenterol Date: 1982-09 Impact factor: 10.864

5. The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors: E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal: Arthritis Rheum Date: 1982-11

6. Hetero- and homozygosity of MHC class II gene products in systemic lupus erythematosus. The Members of the Deutsche Multizentrische SLE-Studie.

Authors: K Hartung; R Coldewey; F Krapf; B Lang; C Specker; D Schendel; P Schneider; S Seuchter; W Stangel; E Albert
Journal: Tissue Antigens Date: 1991-10

Review 1. Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis.

Authors: C P Rains; S Noble; D Faulds
Journal: Drugs Date: 1995-07 Impact factor: 9.546

1 in total

Drug-related lupus in a patient with rheumatoid arthritis under sulfasalazine treatment.

1. Sulphasalazine induced autoimmune syndrome.

2. Sulphasalazine-induced cerebral lupus erythematosus.

3. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

4. Sulfasalazine-induced lupus syndrome in a patient with Crohn's disease.

5. The 1982 revised criteria for the classification of systemic lupus erythematosus.

6. Hetero- and homozygosity of MHC class II gene products in systemic lupus erythematosus. The Members of the Deutsche Multizentrische SLE-Studie.

7. Sulphasalazine-induced systemic lupus erythematosus in a child.

8. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis.

9. Sulfasalazine-induced lupus erythematosus.

10. Sulphasalazine-induced systemic lupus erythematosus in a patient with Sjögren's syndrome.

Review 1. Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis.